Chesapeake Biotech Partners, LLC was formed in March 2004 by Christine Luckscheiter.  Over the last decade, a critical shortage of oncology experienced strategists for cancer drug clinical development and commercialization has occurred.  Chesapeake was launched to provide oncology focused expertise to emerging and established biotech and pharmaceutical companies.  With over 20 years of oncology experience spanning sales, clinical affairs, field scientist management/training, and medical marketing, Christine is known for her ability to create effective pre-launch, launch and post-launch strategic initiatives. Her own portfolio of experience includes the marketed and pipeline oncology products at Adria Laboratories (now Pfizer), Ortho Biotech, Agouron Pharmaceuticals and Astra Zeneca.  Through Chesapeake Biotech Partners, companies have the flexibility of enhancing their internal resources by utilizing external oncology experts.